Obama hosts dinner for Modi ahead of Summit talks

September 30, 2014

Obama Modi DinnerWashington, Sep 30: Ahead of their Summit talks, US President Barack Obama today hosted private dinner for Prime Minister Narendra Modi as the two leaders sought to reinvigorate bilateral ties.

The Prime Minister, who arrived here late afternoon at the Andrew Airforce Base, was received by William Burns, Deputy Secretary of State and other senior officials.

From there, Modi left for the Blair house, the American President's guest house where he will be staying during his Washington trip. Later, he drove to the White House from the Blair guest house for the dinner.

"Kem Cho," asked Obama when he welcomed Modi, who replied, "Thank you very much, President."

The dinner, with limited guests from each side in the Blue Room of the White House might have a delectable spread of dishes, but the main guest only had warm water as he was observing Navratri fasts.

However, First Lady Michelle Obama did not attend the dinner as she was travelling.

"The Prime Minister did not had anything except for warm water," External Affairs Ministry Spokesperson Syed Akabruddin said.

Later, Modi said he had a wonderful meeting with Obama during which they talked about a wide range of issues.

"Obama & I share a vision for a partnership in which our nations work together for the benefit of the entire humankind," the Prime Minister tweeted.

On the issues of discussion during the 90-minute dinner meeting, Akabruddin said discussions were largely on knowing each other and sharing the initial experiences after they took over.

They shared anecdotes to connect with each other, he said while describing the dinner meeting as a "very successful interaction".

"They did not get to discuss any of the substantive issues. This was a very cordial and comforting conversation where each of them were trying to understand others perspective and they did not get into very substantive discussion which will follow tomorrow," he added.

They agreed to take up more substantive issue tomorrow -- both in restrictive format and in delegation level talks -- but in general the thinking was that there was a lot of goodwill between India and the US for each other, he said.

"There was a feeling that they should try and focus on some big things that they can achieve in a finite time period in the next few years," the Spokesperson said.

"There was also a feeling that India-US relationship was among the most important relationships in the world today. And therefore, it was incumbent upon both of them to work towards strengthening and deepening this relationship," he said.

The Prime Minister was asked to outline his vision of what were the issues he faced so far and how he was working on it, the Spokesperson said.

"Remarkably some of those things the Prime Minister mentioned seemed to have resonance with President Obama, because he said he had similar concerns when he came in power.

Giving example of how the two leaders connected, he said Prime Minister told Obama that when he came to Delhi he found that the technological infrastructure in the Indian capital was not even as good as Gujarat to which the US President said he had similar experience.

They both talked about their focus areas of technology and e-governance.

The two leaders have jointly written an editorial in a US newspaper which would be published tomorrow.

Modi also laid out in great details his hopes and aspirations in terms of what was his development vision and how the US can help in achieving that. There was general understanding that the US and India can work not only in terms of bilateral relations but elsewhere in the world, the Spokesperson said, adding in this context they talked about Ebola disease and Afghanistan. These were the two issues that were broadly flagged, he said.

Basically, today's meeting had three major components -connecting with each other, vision for the ties and cooperation in various areas, the Spokesperson added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 18,2020

India is among 58 nations, including 27 European Union members, who have moved a draft resolution demanding evaluation of the World Health Organisation (WHO)'s response towards the novel coronavirus pandemic.

The European Union-led draft resolution on global COVID-19 response is set to be tabled at the upcoming World Health Assembly on Monday.

The draft resolution demands initiation "at the earliest appropriate moment to review experience gained and lessons learned from the WHO-coordinated international health response to COVID-19".

"We are deeply concerned by the morbidity and mortality caused by COVID-19 pandemic, the negative impacts on physical and mental health and social well-being, the negative impacts on economy and society and the consequent exacerbation of inequalities within and between countries," read the draft.

"We express solidarity to all countries affected by the pandemic, as well as condolences and sympathy to all the families of the victims of COVID-19," it added.

The resolution says timelines are to be evaluated regarding "recommendations the WHO made to improve global pandemic prevention, preparedness, and response capacity".

The WHO on January 23 declare a global health emergency, but did not declare it and waited for a week for its director-general Tedros Adhanom Ghebreyesus to return from China.

By that time, COVID-19 cases increased 10 times and the virus entered 18 countries.

According to Health Policy Watch, till as late as February, the WHO did not support countries for imposing travel restrictions to China.

"When countries began evacuating their citizens from Wuhan, the COVID-19 epicentre, the WHO said it did not favour this step".

The WHO finally declared it a pandemic on March 11.

The global health body has come under criticism not just from the US for its response being "China-centric".

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 29,2020

Kolkata, Jun 29: Sweet-loving Bengalis have something to cheer about in COVID-19 time as the West Bengal government decided to come out with a "sandesh" which will contain honey from Sundarbans and increase immunity, an official said on Sunday.

Cotton cheese made from cow milk will be mixed with pure honey from the Sunderbans to prepare the "Arogya Sandesh" which will also have extracts of tulsi leaves, an official of the Animal Resources Development Department said.

No artificial flavours would be added to the sweetmeat which will be available in the department's outlets in the city and neighbouring districts, he said.

The sandesh will boost the immune system as a whole but it is not a COVID-19 antidote, the official said.

Sunderbans Affairs Minister Manturam Pakhira said the honey for making Arogya Sandesh will be collected from beehives in places such as Pirkhali, Jharkhali and other parts of the Sunderbans and it will be stored in a scientific manner.

The sandesh is expected to hit the shelves in another two months and the pricing will be within the reach of the common man, the animal resources development department official said.

Earlier this month, a reputed sweetmeat chain of Kolkata came out with an "Immunity Sandesh" claiming that it contains various herbs and spices such as haldi (turmeric), tulsi, saffron, and cardamom and Himalayan honey, which will boost immunity to fight novel coronavirus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 6,2020

New Delhi, Jul 6: The Indian Academy of Sciences, a Bengaluru-based body of scientists, has said the Indian Council for Medical Research's (ICMR) target to launch a coronavirus vaccine by August 15 is "unfeasible" and "unrealistic".

The IASc said while there is an unquestioned urgent need, vaccine development for use in humans requires scientifically executed clinical trials in a phased manner.

While administrative approvals can be expedited, the "scientific processes of experimentation and data collection have a natural time span that cannot be hastened without compromising standards of scientific rigour", the IASc said in a statement.

In its statement, the IASc referred to the ICMR's letter which states that "it is envisaged to launch the vaccine for public health use latest by 15th August 2020 after completion of all clinical trials".

The ICMR and Bharat Biotech India Limited, a private pharmaceutical company, are jointly developing the vaccine against the novel coronavirus -- SARS-CoV-2.

The IASc welcomes the exciting development of a candidate vaccine and wishes that the vaccine is quickly made available for public use, the statement said.

"However, as a body of scientists including many who are engaged in vaccine development IASc strongly believes that the announced timeline is unfeasible. This timeline has raised unrealistic hope and expectations in the minds of our citizens," it said.

Aiming to launch an indigenous COVID-19 vaccine by August 15, the ICMR had written to select medical institutions and hospitals to fast-track clinical trial approvals for the vaccine candidate, COVAXIN.

Experts have also cautioned against rushing the process for developing a COVID-19 vaccine and stressed that it is not in accordance with the globally accepted norms to fast-track vaccine development for diseases of pandemic potential.

The IASc said trials for a vaccine involve evaluation of safety (Phase 1 trial), efficacy and side effects at different dose levels (Phase 2 trial), and confirmation of safety and efficacy in thousands of healthy people (Phase 3 trial) before its release for public use.

Clinical trials for a candidate vaccine require participation of healthy human volunteers. Therefore, many ethical and regulatory approvals need to be obtained prior to the initiation of the trials, it added.

The IASc said the immune responses usually take several weeks to develop and relevant data should not be collected earlier.

"Moreover, data collected in one phase must be adequately analysed before the next phase can be initiated. If the data of any phase are unacceptable then the clinical trial is required to be immediately aborted," it said.

For example, if the data collected from Phase 1 of the clinical trial show that the vaccine is not adequately safe, then Phase 2 cannot be initiated and the candidate vaccine must be discarded.

For these reasons, the Indian Academy of Sciences believes that the announced timeline is "unreasonable and without precedent", the statement said.

"The Academy strongly believes that any hasty solution that may compromise rigorous scientific processes and standards will likely have long-term adverse impacts of unforeseen magnitude on citizens of India," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.